PRICE T ROWE ASSOCIATES INC /MD/ - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$53,857,000
-29.1%
356,257
-31.7%
0.01%
-10.0%
Q2 2022$75,999,000
+24.3%
521,580
+1.1%
0.01%
+66.7%
Q1 2022$61,155,000
-4.8%
515,771
+10.7%
0.01%0.0%
Q4 2021$64,216,000
+9.0%
465,977
+9.8%
0.01%0.0%
Q3 2021$58,928,000
+63.7%
424,217
+14.4%
0.01%
+100.0%
Q2 2021$35,990,000
+240.7%
370,729
+139.9%
0.00%
+200.0%
Q1 2021$10,563,000
-20.3%
154,547
-0.1%
0.00%0.0%
Q4 2020$13,261,000
+688.4%
154,716
+497.9%
0.00%
Q3 2020$1,682,000
-9.8%
25,876
+1.4%
0.00%
Q2 2020$1,865,000
+108.8%
25,510
-2.8%
0.00%
Q1 2020$893,000
-36.4%
26,238
+1.8%
0.00%
Q4 2019$1,403,000
+46.6%
25,776
+12.4%
0.00%
Q3 2019$957,000
+16.0%
22,930
+21.8%
0.00%
Q2 2019$825,000
-91.8%
18,831
-95.0%
0.00%
-100.0%
Q4 2017$10,119,000
-27.6%
375,048
+0.3%
0.00%0.0%
Q3 2017$13,978,000
+12.7%
373,948
-24.6%
0.00%0.0%
Q2 2017$12,403,000496,1280.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders